ООО «Лабораторная Диагностика»
ООО «Лабораторная Диагностика»  
 Главная   Новости   О компании  Каталог продукции и цены   Оформить заказ   Контакты 
 
  
Каталог продукции
  Гематология  
  Гемостаз  
  Иммуногематология  
  Иммуногистохимия
  Иммуноферментный анализ (ИФА)
  Иммунохимия  
  Клеточные технологии  
  Клиническая биохимия
  Коагулометрия  
  Микробиология  
  Мультиплексный анализ  
  Оборудование для биохимии и
  молекулярной биологии
  Общелабораторное оборудование
  Онкология  
  Пищевая промышленность  
  Программное обеспечение  
  Проточная цитометрия
  ПЦР-лаборатория
  Рекомбинантные белки
  Репродуктивные технологии
  Сортировка клеток
  Спектрофотометрия  
  Стволовые клетки (Stem Cells)
  Трансплантология
  Цитогенетическая диагностика
  Экспресс-лаборатория  

 
/ Обзоры и публикации

HLA-ассоциированные случаи диабета

Описанные в литературе HLA-ассоциированные случаи диабета

HLA аллель

Источник

DRB1*01

[1-8]

DRB1*03

[5, 9-12]

DRB1*0301       

[1, 4, 6-8, 13-18]

DRB1*04

[1, 2, 5-7, 9, 10, 12, 16-18]

DRB1*0401

[4, 7, 8, 10, 11, 13, 15, 16]

DRB1*0402

[7, 8, 13]

DRB1*0403

[7, 8, 12-14, 19]

DRB1*0404

[7, 8, 12, 13, 16]

DRB1*0405

[7, 8, 12, 14, 16, 19]

DRB1*0406

[14]

DRB1*0407

[7, 14]

DRB1*0408

[7, 11]

DRB1*07

[7, 8, 16, 20, 21]

DRB1*08

[1, 7, 8, 22, 23]

DRB1*0802

[19]

DRB1*09

[7, 17, 24]

DRB1*0901

[7, 14, 19]

DRB1*10

[7, 14]

DRB1*11

[7, 12, 21]

DRB1*12

[7, 14, 16]

DRB1*13

[5-7, 21]

DRB1*1301

[25]

DRB1*1302

[2]

DRB1*14

[7, 14]

DRB1*15

[5, 7, 14]

DRB1*1501

[2, 4, 8, 9, 12, 26, 27]

DRB1*1503

[11]

DRB1*16

[7, 28]

DRB3*0101

[20]

DRB3*0200

[29, 30]

DRB5

[28, 31]

DRB5*0101

[2, 15, 26, 27]

DQ2

[5, 7-9, 12, 16]

DQB*0201

[8, 9, 12, 14, 15, 32]

DQ7

[5]

DQB*0301

[7, 12, 14, 16, 28, 33]

DQ8

[5, 11, 12, 34]

DQB*0302

[7, 9, 10, 12-14, 16, 32]

DQB*0303

[7, 8, 19, 24, 33, 35]

DQB*0401

[7, 10, 14, 19]

DQB*0402

[7, 11, 12, 23, 33]

DQ5

[5]

DQB1*05

[7, 16, 27, 33, 36]

DQB*06

[5, 7, 11]

DQB*0601

[7, 14]

DQB*0602

[7, 9, 12, 14, 27, 32]

DQB*0603

[7, 32, 36]

DQB*0604

[7, 32, 33]

Литература

1. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA: The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996, 59:1134-1148.

2. Bach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM: High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. Journal of Autoimmunity 1997, 10:375-386.

3. Bach JM, Otto H, Jung G, Cohen H, Boitard C, Bach JF, van Endert PM: Identification of mimicry peptides based on sequential motifs of epitopes derived from 65-kDa glutamic acid decarboxylase. Eur J Immunol 1998, 28:1902-1910.

4. Geluk A, van Meijgaarden KE, Schloot NC, Drijfhout JW, Ottenhoff TH, Roep BO: HLA-DR binding analysis of peptides from islet antigens in IDDM. Diabetes 1998, 47:1594-1601.

5. Shtauvere A, Rumba I, Dzivite I, Sanjeevi CB: HLA-DR and -DQ gene polymorphism in Latvian patients with insulin-dependent diabetes mellitus. Tissue Antigens 1998, 52:385-388.

6. Bearzatto M, Naserke H, Piquer S, Koczwara K, Lampasona V, Williams A, Christie MR, Bingley PJ, Ziegler AG, Bonifacio E: Two distinctly HLA-associated contiguous linear epitopes uniquely expressed within the islet antigen 2 molecule are major autoantibody epitopes of the diabetes-specific tyrosine phosphatase-like protein autoantigens. J Immunol 2002, 168:4202-4208.

7. Thomson G, Valdes AM, Noble JA, Kockum I, Grote MN, Najman J et al.: Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 2007, 70:110-127.

8. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P et al.: HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008, 57:1084-1092.

9. Leech NJ, Kitabchi AE, Gaur LK, Hagopian WA, Hansen J, Burghen GA, Palmer JP, Nepom GT: Genetic and immunological markers of insulin dependent diabetes in Black Americans. Autoimmunity 1995, 22:27-32.

10. Park YS, She JX, Noble JA, Erlich HA, Eisenbarth GS: Transracial evidence for the influence of the homologous HLA DR-DQ haplotype on transmission of HLA DR4 haplotypes to diabetic children. Tissue Antigens 2001, 57:185-191.

11. Heward JM, Mijovic CH, Kelly MA, Morrison E, Barnett AH: HLA-DQ and DRB1 polymorphism and susceptibility to type 1 diabetes in Jamaica. Eur J Immunogenet 2002, 29:47-52.

12. Abid Kamoun H, Hmida S, Kaabi H, Abid A, Slimane Houissa H, Maamar M et al.: HLA polymorphism in type 1 diabetes Tunisians. Ann Genet 2002, 45:45-50.

13. Harfouch-Hammoud E, Timsit J, Boitard C, Bach JF, Caillat-Zucman S: Contribution of DRB1*04 variants to predisposition to or protection from insulin dependent diabetes mellitus is independent of dq. J Autoimmun 1996, 9:411-414.

14. Park YS, Wang CY, Ko KW, Yang SW, Park M, Yang MC, She JX: Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans. Hum Immunol 1998, 59:794-801.

15. Harfouch-Hammoud E, Walk T, Otto H, Jung G, Bach JF, van Endert PM, Caillat-Zucman S: Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes. Diabetes 1999, 48:1937-1947.

16. Petrone A, Bugawan TL, Mesturino CA, Nistico L, Galgani A, Giorgi G, Cascino I, Erlich HA, Di Mario U, Buzzetti R: The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region). Tissue Antigens 2001, 58:385-394.

17. Chen BH, Chung SB, Chiang W, Chao MC: GAD65 antibody prevalence and association with thyroid antibodies, HLA-DR in Chinese children with type 1 diabetes mellitus. Diabetes Res Clin Pract 2001, 54:27-32.

18. Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA et al.: Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun 2006, 7:550-554.

19. Maruyama T, Shimada A, Kasuga A, Kasatani T, Ozawa Y, Ishii M et al.: Analysis of MHC class II antigens in Japanese IDDM by a novel HLA-typing method, hybridization protection assay. Diabetes Res Clin Pract 1994, 23:77-84.

20. Todd JA, Bell JI, McDevitt HO: HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987, 329:599-604.

21. Balducci-Silano PL, Layrisse Z, Dominguez E, Amaro R, Gunczler P, Lanes R, Zaro R: HLA-DQA1 and DQB1 allele and genotype contribution to IDDM susceptibility in an ethnically mixed population. Eur J Immunogenet 1994, 21:405-414.

22. Thomson G: HLA DR antigens and susceptibility to insulin-dependent diabetes mellitus. Am J Hum Genet 1984, 36:1309-1317.

23. Dubois-Laforgue D, Timsit J, Djilali-Saiah I, Boitard C, Caillat-Zucman S: Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects. Hum Immunol 1997, 57:104-109.

24. Lee HC, Ikegami H, Fujisawa T, Ogihara T, Park SW, Chung YS et al.: Role of HLA class II alleles in Korean patients with IDDM. Diabetes Res Clin Pract 1996, 31:9-15.

25. Mbanya JC, Sobngwi E, Mbanya DN: HLA-DRB1, -DQA1, -DQB1 and DPB1 susceptibility alleles in Cameroonian type 1 diabetes patients and controls. Eur J Immunogenet 2001, 28:459-462.

26. Vogt AB, Kropshofer H, Kalbacher H, Kalbus M, Rammensee HG, Coligan JE, Martin R: Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol 1994, 153:1665-1673.

27. Reijonen H, Ilonen J, Akerblom HK, Knip M, Dosch HM: Multi-locus analysis of HLA class II genes in DR2-positive IDDM haplotypes in Finland. The "Childhood Diabetes in Finland" (DiMe) Study Group. Tissue Antigens 1994, 43:1-6.

28. Sanjeevi CB, Lybrand TP, Landin-Olsson M, Kockum I, Dahlquist G, Hagopian WA, Palmer JP, Lernmark A: Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus. Tissue Antigens 1994, 44:110-119.

29. Buyse I, Sandkuyl LA, Zamani Ghabanbasani M, Gu XX, Bouillon R, Bex M et al.: Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population. Diabetologia 1994, 37:808-817.

30. Mehra NK, Kaur G, Kanga U, Tandon N: Immunogenetics of autoimmune diseases in Asian Indians. Ann N Y Acad Sci 2002, 958:333-336.

31. Zeliszewski D, Tiercy JM, Boitard C, Gu XF, Loche M, Krishnamoorthy R et al.: Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients. Hum Immunol 1992, 33:140-147.

32. Sanjeevi CB: HLA-DQ6-mediated protection in IDDM. Hum Immunol 2000, 61:148-153.

33. Undlien DE, Kockum I, Ronningen KS, Lowe R, Saanjeevi CB, Graham J, Lie BA, Akselsen HE, Lernmark A, Thorsby E: HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes. Tissue Antigens 1999, 54:543-551.

34. Kelemen K, Gottlieb PA, Putnam AL, Davidson HW, Wegmann DR, Hutton JC: HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes. J Immunol 2004, 172:3955-3962.

35. Graham J, Kockum I, Sanjeevi CB, Landin-Olsson M, Nystrom L, Sundkvist G et al.: Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group. Eur J Immunogenet 1999, 26:117-127.

36. Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, Sipila I, Akerblom HK, Ilonen J: HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003, 62:162-169.

   
© ООО «Лабораторная Диагностика»,  info@LD.ru
телефоны: +7 (495) 461-67-60, +7 (499) 348-25-72